The Growing Biomaterial Industry: Trends, Market Segmentation, and Future Outlook

The biomaterials industry has witnessed significant growth and economic advancement in recent decades, with a projected market value of $217.6 billion by 2027.

In the last few decades, the biomaterials industry has experienced remarkable growth in both the number of products available and their economic significance. The market related to biomaterials is substantial, considering the number of units sold annually and the financial turnover observed. It can be conveniently segmented based on two main criteria: the types of compounds used to make biomaterials and their applications.

The types of compounds used in biomaterials include metals, ceramics, polymers, and materials of natural origin. Additionally, biomaterials can be categorised based on their applications, such as orthopaedic, cardiovascular, dental, ophthalmologic, plastic surgery, tissue engineering, injury treatment, neurological and central nervous system disorders, as well as devices for gastrointestinal and urinary applications, drug delivery systems, and bariatric surgery.

However, there are several additional ways to segment the biomaterial market, including by end user, geography, technological advancement, phase of product life cycle, price point, regulatory approval status, manufacturing process, and target patient population.

According to a 2022 report by Market Data Forecast [4], the global biomaterials market was estimated to be worth $110.6 billion in 2022, with a predicted compound annual growth rate (CAGR) of 14.5%. Other experts’ predictions of the CAGR vary between 12.2% and 15.4%, all indicating substantial growth of the biomaterials market.

The intense growth observed in the biomaterials market can be attributed to several factors:

Aging population: As the population ages, there is a greater demand for medical devices and procedures that rely on biomaterials. The prevalence of conditions like osteoarthritis and cardiovascular disease is expected to increase, leading to a higher demand for hip and knee replacements, cardiovascular stents, and other medical devices.

Increasing prevalence of chronic diseases: Obesity, diabetes, and cardiovascular disease are on the rise, driving the demand for medical devices and treatments that use biomaterials. Weight loss surgery and insulin pumps are examples of procedures that utilize biomaterials to address these chronic conditions.

Technological advances: Significant advancements in biomaterial design and manufacturing techniques have expanded the range of applications for biomaterials. Techniques like 3D printing have enabled the creation of customized medical devices and implants, while porous biomaterials have improved tissue growth and repair capabilities.

Government funding and regulatory support: Governments worldwide are investing in biomaterial research and providing regulatory support for their use in medical applications. This support facilitates the development and market entry of new biomaterial-based products.

Growing awareness of the benefits of biomaterials: The awareness of biomaterials’ biocompatibility and their ability to improve patient outcomes has led to an increasing demand for these materials. Biomaterials are being used in drug delivery systems, tissue engineering, and regenerative medicine to enhance treatment outcomes.

Orthopaedic implants are currently the most successful segment in terms of sales globally. Other prominent branches include biomaterials for cardiovascular applications, dentistry, wound care, and plastic surgery. Key applications identified are bone regeneration, soft tissue regeneration, joint replacements, implants, and instrumentation.

Metallic biomaterials dominate the global market, followed by ceramics, polymers, and composites. However, the market for polymeric biomaterials is expected to grow due to their improved characteristics, such as flexibility, elasticity, biological inertness, biocompatibility, and longevity.

The North American region, including Canada, holds the largest market share for biomaterials, followed by Europe. However, the fastest-growing market is in the Asia Pacific region. The growth in North America can be attributed to increased biomaterial-based research, rising demand for plastic surgeries, the growing incidence of cancer, and the prevalence of cardiovascular diseases.

The biomaterials industry is competitive, with major players in the market. However, no single company or group dominates the industry due to its diverse nature.

The biomaterial market is influenced by several trends. The increasing use of 3D printing technology enables the customisation of medical devices and implants, enhancing patient outcomes. Biodegradable and bioresorbable biomaterials are being developed, offering potential applications in drug delivery systems, tissue engineering, and medical devices. Bioactive materials that interact with living tissue to promote healing are gaining interest in the industry. Moreover, natural materials derived from sources like collagen and chitosan are being utilised due to their biocompatibility. Smart materials that can adapt to the environment or deliver drugs in a controlled manner are also emerging.

Most companies in the biomaterial industry rely on equity as their primary source of investment, followed by research and development projects and loans. These companies often have multiple sources of investment to support their operations.

While the biomaterial industry presents numerous opportunities for growth and innovation, it also faces various challenges. Some of these challenges include regulatory hurdles, the high cost of research and development, limited availability of raw materials, and ethical concerns surrounding the use of certain biomaterials.

In conclusion, the biomaterial industry is experiencing significant growth and offers promising prospects for the future. Factors such as an ageing population, increasing prevalence of chronic diseases, technological advances, government funding, and growing awareness of the benefits of biomaterials are driving this growth. Trends like 3D printing, biodegradable materials, bioactive materials, natural materials, and smart materials are shaping the industry. Despite its challenges, the biomaterials industry is poised for further innovation and expansion in the medical and healthcare sectors.

Author: Fábio Grilo








biomaterials industry, aging population, chronic diseases, technological advances, government support, awareness, regulatory environment, trends, challenges.